Shawn Tomasello

Insider Reports History

Location
Sunnyvale, CA
Signature
By: /s/ Michael Gerard, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Shawn Tomasello:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gamida Cell Ltd. Director Ordinary Shares 241,977 $375,064 $1.55 31 Jan 2024 Direct
Allovir, Inc. Director Common Stock 70,000 $55,461 $0.7923 06 Jun 2024 Direct
Cabaletta Bio, Inc. Director Common Stock 22,725 $50,322 $2.21 21 Jan 2026 By Shawn Tomasello Consulting LLC
4D Molecular Therapeutics, Inc. Director Stock Option (Right to Buy) 22,500 17 Jun 2025 Direct
Cabaletta Bio, Inc. Director Stock Option (Right to Buy) 22,000 09 Jun 2025 Direct
Gamida Cell Ltd. Director Share Option (Right to Buy) 17,000 19 Oct 2023 Direct
UroGen Pharma Ltd. Director Stock Option (right to buy) 10,000 07 Jun 2021 Direct
TCR2 THERAPEUTICS INC. Director Stock Option (Right to Buy) 0 $0.7400 01 Jun 2023 Direct

Insider Reports Filed by Shawn Tomasello

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CABA Cabaletta Bio, Inc. 21 Jan 2026 1 +$50,322 4 Director 21 Jan 2026, 18:55
FDMT 4D Molecular Therapeutics, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:04
CABA Cabaletta Bio, Inc. 09 Jun 2025 1 $0 4 Director 09 Jun 2025, 20:17
CABA Cabaletta Bio, Inc. 19 May 2025 4 $0 4 Director 19 May 2025, 21:38
KLRS Allovir, Inc. 06 Jun 2024 1 $0 4 Director 07 Jun 2024, 16:05
CABA Cabaletta Bio, Inc. 03 Jun 2024 1 $0 4 Director 04 Jun 2024, 19:14
FDMT 4D Molecular Therapeutics, Inc. 21 May 2024 1 $0 4 Director 23 May 2024, 20:45
/report/000141588924002335-tomasello-shawn-2024-01-31 Gamida Cell Ltd. 31 Jan 2024 1 $0 4 Director 02 Feb 2024, 16:45
/report/000120919123053267-tomasello-shawn-2023-10-19-restatement Gamida Cell Ltd. 19 Oct 2023 1 $0 4/A Director 20 Oct 2023, 16:39
/report/000120919123053265-tomasello-shawn-2023-10-19-restatement Gamida Cell Ltd. 19 Oct 2023 2 $0 4/A Director 20 Oct 2023, 16:38
CABA Cabaletta Bio, Inc. 21 Jul 2023 1 $0 4 Director 24 Jul 2023, 08:26
CABA Cabaletta Bio, Inc. 21 Jul 2023 0 $0 3 Director 24 Jul 2023, 08:24
/report/000110465923067078-tomasello-shawn-2023-06-01 TCR2 THERAPEUTICS INC. 01 Jun 2023 4 $0 4 Director 01 Jun 2023, 16:32
FDMT 4D Molecular Therapeutics, Inc. 23 May 2023 1 $0 4 Director 25 May 2023, 19:39
KLRS Allovir, Inc. 11 May 2023 1 $0 4 Director 12 May 2023, 17:00
/report/000120919123020521-tomasello-shawn-2023-03-20 Gamida Cell Ltd. 20 Mar 2023 1 $0 4 Director 22 Mar 2023, 16:34
/report/000120919123008551-tomasello-shawn-2023-02-08 Gamida Cell Ltd. 08 Feb 2023 2 $0 4 Director 10 Feb 2023, 18:30
/report/000089924322039011-tomasello-shawn-2022-12-15 TCR2 THERAPEUTICS INC. 15 Dec 2022 1 $0 4 Director 19 Dec 2022, 16:10
/report/000120919122058395-tomasello-shawn-2022-11-18 Gamida Cell Ltd. 18 Nov 2022 2 $0 4 Director 22 Nov 2022, 15:37
/report/000120919122052284-tomasello-shawn-2022-09-30 Gamida Cell Ltd. 30 Sep 2022 1 +$14,999 4 Director 04 Oct 2022, 16:39
FDMT 4D Molecular Therapeutics, Inc. 23 May 2022 1 $0 4 Director 25 May 2022, 19:08
KLRS Allovir, Inc. 17 May 2022 1 $0 4 Director 19 May 2022, 16:20
KLRS Allovir, Inc. 29 Mar 2022 1 $0 4 Director 31 Mar 2022, 17:20
KLRS Allovir, Inc. 29 Mar 2022 0 $0 3 Director 31 Mar 2022, 17:18
/report/000120919122000168-tomasello-shawn-2022-01-01 Gamida Cell Ltd. 01 Jan 2022 0 $0 3 Director 03 Jan 2022, 15:23
/report/000120919121069058-tomasello-shawn-2021-12-09 TCR2 THERAPEUTICS INC. 09 Dec 2021 1 $0 4 Director 10 Dec 2021, 15:35
URGN UroGen Pharma Ltd. 07 Jun 2021 1 $0 4 Director 09 Jun 2021, 13:43
FDMT 4D Molecular Therapeutics Inc. 17 May 2021 1 $0 4 Director 19 May 2021, 20:31